Sagimet Biosciences (NASDAQ:SGMT) used a presentation at Guggenheim’s Emerging Outlook Conference to highlight its strategy ...
Shares of Sagimet Biosciences were up as much as 12% after encouraging clinical trial results for its acne treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results